Calamos Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-40,789
Closed -$755K 920
2025
Q1
$755K Buy
40,789
+9,064
+29% +$164K ﹤0.01% 679
2024
Q4
$523K Buy
+31,725
New +$449K ﹤0.01% 725
2021
Q2
Sell
-145,600
Closed -$2.95M 958
2021
Q1
$2.95M Buy
145,600
+72,062
+98% +$1.42M 0.02% 643
2020
Q4
$1.32M Buy
+73,538
New +$1.08M 0.01% 668

Other funds holding AXGN

Calamos Advisors's AXGN Position: Q2 2025 in Review

Calamos Advisors sold out of Axogen (AXGN) in Q2 2025, closing a stake of 40,789 shares — an estimated $755K sold.

Calamos Advisors first reported a position in AXGN in Q4 2020 and held it in 4 quarters. The position peaked at $2.95M in Q1 2021. 155 funds tracked by Wall St. Rank hold AXGN as of Q2 2025.

  • Calamos Advisors reported no remaining Axogen position as of Q2 2025 after selling out during the quarter.
  • Calamos Advisors sold 40,789 Axogen shares in Q2 2025, an estimated $755K.
  • Calamos Advisors first reported a position in Axogen in Q4 2020 and held it in 4 quarters.
  • Calamos Advisors's Axogen position peaked at $2.95M in Q1 2021.
  • 155 funds tracked by Wall St. Rank held Axogen as of Q2 2025.

Based on Calamos Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.